Channel: Rapamycin and ageing

Sirolimus, also known as rapamycin and sold under the brand name Rapamune among others, is a macrolide compound that is used to coat coronary stents, prevent organ transplant rejection, treat a rare lung disease called lymphangioleiomyomatosis, and treat perivascular epithelioid cell tumor (PEComa). It has immunosuppressant functions in humans and is especially useful in preventing the rejection of kidney transplants. It is a mechanistic target of rapamycin kinase (mTOR) inhibitor that inhibits activation of T cells and B cells by reducing their sensitivity to interleukin-2 (IL-2). It has been shown to play a role in slowing ageing. Wikipedia (CC BY-SA 3.0)

    2023 Articles

    31 331 articles

    TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : Several Distinct Entities or a Tumor Family?

    Comment Section

    Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?

    • Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny
    • Aging (Albany NY), 10.18632/aging.204920
    Comment Section

    Cancer prevention with rapamycin

    • Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny, Mikhail V Blagosklonny
    • Oncotarget, 10.18632/oncotarget.28410
    Comment Section

    Investigating trajectories of aging using high-dimensional phenotyping in mice

    • Michael R MacArthur, Sarah J Mitchell, Michael R MacArthur, …, Sarah J Mitchell, Michael R MacArthur, Sarah J Mitchell
    • Lab Anim (NY), 10.1038/s41684-023-01122-3
    Comment Section

    Targeting the biology of aging with mTOR inhibitors

    • Joan B Mannick, Joan B Mannick, Joan B Mannick, …, Joan B Mannick, Joan B Mannick, Dudley W Lamming
    • Nat Aging, 10.1038/s43587-023-00416-y
    Comment Section

    Evaluation of off-label rapamycin use to promote healthspan in 333 adults

    • Tammi L Kaeberlein, Alan S Green, George Haddad, …, Mikhail V Blagosklonny, Jonathan Y An, Matt Kaeberlein
    • Geroscience, 10.1007/s11357-023-00818-1
    Comment Section

    A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors

    • Blessie Elizabeth Nelson, Apostolia M Tsimberidou, Xueyao Fu, …, Scott Kopetz, Shubham Pant, Sarina A Piha-Paul
    • Oncologist, 10.1093/oncolo/oyad158
    Comment Section

    Perivascular epithelioid cell tumor (PEComa) of the female genital tract

    • Katelyn Zebrowski, Katelyn Zebrowski, David B Chapel, Katelyn Zebrowski, David B Chapel
    • Int J Gynecol Cancer, 10.1136/ijgc-2022-004212
    Comment Section

    Commentary on “Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes”

    Comment Section

    Geroscience for the Next Chapter of Medicine

    • Gustavo Duque, Lewis Lipsitz, Luigi Ferrucci, …, Siobhan Addie, Stacy Carrington-Lawrence, Ronald Kohanski
    • J Gerontol A Biol Sci Med Sci, 10.1093/gerona/glad083
    Comment Section

    2022 Articles

    3 542 articles

    Discovery of small molecule mechanistic target of rapamycin inhibitors as anti-aging and anti-cancer therapeutics

    • Zofia Chrienova, David Rysanek, Patrik Oleksak, …, Kamil Kuca, Zdenek Hodny, Eugenie Nepovimova
    • None, 10.3389/fnagi.2022.1048260
    Comment Section

    Sex Matters in Aging. The Canagliflozin Story

    Comment Section

    Mammalian Target of Rapamycin Inhibitors and Kidney Function After Thoracic Transplantation: A Systematic Review and Recommendations for Management of Lung Transplant Recipients

    • Katja Schmucki, Patrick Hofmann, Thomas Fehr, …, Ilhan Inci, Malcolm Kohler, MacĂ© M Schuurmans
    • Transplantation, 10.1097/tp.0000000000004336
    Comment Section

    IDH-mutant glioma: A new IDH1 inhibitor moves forward

    • Julie J Miller, Isabel Arrillaga-Romany, Julie J Miller, Isabel Arrillaga-Romany, Julie J Miller, Isabel Arrillaga-Romany
    • Neuro Oncol, 10.1093/neuonc/noac275
    Comment Section

    mTOR inhibitors in a patient with lupus nephritis; why not?

    Comment Section

    Queueing theory model of mTOR complexes’ impact on Akt-mediated adipocytes response to insulin

    • Sylwester M Kloska, Krzysztof PaƂczyƄski, Tomasz Marciniak, …, Paul H Davis, Ghada A Soliman, Tadeusz A Wysocki
    • PLoS One, 10.1371/journal.pone.0279573
    Comment Section

    Muscle 4EBP1 activation modifies the structure and function of the neuromuscular junction in mice

    • Seok-Ting J Ang, Elisa M Crombie, Han Dong, …, Dominic J Withers, Hua Huang, Shih-Yin Tsai
    • Nat Commun, 10.1038/s41467-022-35547-0
    Comment Section

    Mechanisms of Resistance in Gastroenteropancreatic Neuroendocrine Tumors

    Comment Section

    Soft-Shelled Turtle Peptides Extend Lifespan and Healthspan in Drosophila

    • Qianqian Wang, Junhui Zhang, Jiachen Zhuang, …, Peng Yu, Hao Zhong, Fengqin Feng
    • Nutrients, 10.3390/nu14245205
    Comment Section

    Invasive management of non-ST elevation myocardial infarction (NSTEMI) in a patient with severe thrombocytopenia secondary to adult-onset immune thrombocytopenic purpura

    • Asif Muhammad, Benjamin Davison, Syed Yaseen Naqvi, …, Asif Muhammad, Benjamin Davison, Syed Yaseen Naqvi
    • BMJ Case Rep, 10.1136/bcr-2022-253140
    Comment Section